Učitavanje...
Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice
BACKGROUND: Although cisplatin is one of the most effective chemotherapeutic agents, cisplatin alone does not achieve a satisfactory therapeutic outcome. Also cisplatin accumulation shows toxicity to normal tissues. In this study, we examined the possibility of HemoHIM both to enhance anticancer eff...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2009
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2666758/ https://ncbi.nlm.nih.gov/pubmed/19292900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-85 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|